Pharmacological therapies remain an essential component of dry eye management and should be selected according to the underlying tear-film, inflammatory and ocular surface abnormalities. Lubricants, anti-inflammatory agents, immunomodulators and other targeted treatments can complement interventional procedures within a personalized strategy.